ZAHRA (JOURNAL OF HEALTH AND MEDICAL RESEARCH)
Vol. 4 No. 1 (2024): ZAHRA (JOURNAL OF HEALTH AND MEDICAL RESEARCH)

EMPAGLIFLOZIN: TERAPI BARU UNTUK PASIEN GAGAL JANTUNG DENGAN KOMORBID DIABETES MELLITUS TIPE 2 (DMT2)

Maha Fitra ND (Program Studi Spesialis-1 Jantung dan Pembuluh Darah Fakultas Kedokteran Universitas Syiah Kuala, Indonesia)

Article Info

Publish Date
15 Jan 2026

Abstract

Type 2 diabetes mellitus (DMT2) and heart failure have a strong relationship and one clinical outcome affects the other. Recent studies have succeeded in proving the benefits of empagliflozin, an SGLT2 inhibitor class drug (second-line drug for T2DM), on the cardiovascular system. In addition to the diuretic role, the cellular mechanism of empagliflozin that is known to play a role in animals is myocardial anti-fibrosis effect.

Copyrights © 2024




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
ZAHRA (JOURNAL OF HEALTH AND MEDICAL RESEARCH)
Website

Abbrev

ZAHRA

Publisher

CV. Adiba Aisha Amira

Subject

Description

ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH focuses on health sciences, including preventive, promotive, curative, and rehabilitative fields, by publishing "original articles" and "review articles." The scientific scope of the Health Scientific Journal includes: Medical and clinical research ...